• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体δ可减轻结肠癌发生。

Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

作者信息

Harman Fred S, Nicol Christopher J, Marin Holly E, Ward Jerrold M, Gonzalez Frank J, Peters Jeffrey M

机构信息

Department of Veterinary Science and The Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.

出版信息

Nat Med. 2004 May;10(5):481-3. doi: 10.1038/nm1026. Epub 2004 Mar 28.

DOI:10.1038/nm1026
PMID:15048110
Abstract

Peroxisome proliferator-activated receptor-delta (PPAR-delta; also known as PPAR-beta) is expressed at high levels in colon tumors, but its contribution to colon cancer is unclear. We examined the role of PPAR-delta in colon carcinogenesis using PPAR-delta-deficient (Ppard(-/-)) mice. In both the Min mutant and chemically induced mouse models, colon polyp formation was significantly greater in mice nullizygous for PPAR-delta. In contrast to previous reports suggesting that activation of PPAR-delta potentiates colon polyp formation, here we show that PPAR-delta attenuates colon carcinogenesis.

摘要

过氧化物酶体增殖物激活受体δ(PPAR-δ;也称为PPAR-β)在结肠肿瘤中高表达,但其对结肠癌的作用尚不清楚。我们使用PPAR-δ缺陷(Ppard(-/-))小鼠研究了PPAR-δ在结肠癌发生中的作用。在Min突变体和化学诱导的小鼠模型中,PPAR-δ纯合缺失的小鼠结肠息肉形成明显更多。与之前报道的PPAR-δ激活会增强结肠息肉形成相反,我们在此表明PPAR-δ可减弱结肠癌发生。

相似文献

1
Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.过氧化物酶体增殖物激活受体δ可减轻结肠癌发生。
Nat Med. 2004 May;10(5):481-3. doi: 10.1038/nm1026. Epub 2004 Mar 28.
2
Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.过氧化物酶体增殖物激活受体δ对胎盘形成、肥胖和结直肠癌的影响。
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):303-8. doi: 10.1073/pnas.012610299. Epub 2001 Dec 26.
3
Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?核受体。I. 胃肠道中的过氧化物酶体增殖物激活受体γ:获益还是痛苦?
Am J Physiol Gastrointest Liver Physiol. 2002 Apr;282(4):G581-5. doi: 10.1152/ajpgi.00508.2001.
4
APC-dependent suppression of colon carcinogenesis by PPARgamma.过氧化物酶体增殖物激活受体γ(PPARγ)通过依赖于活化蛋白C(APC)抑制结肠癌发生。
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6. doi: 10.1073/pnas.162480299. Epub 2002 Oct 7.
5
[Peroxisome proliferator-activated receptor beta(delta) (PPAR beta(delta))].
Nihon Rinsho. 2001 Feb;59 Suppl 2:301-4.
6
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.核激素受体过氧化物酶体增殖物激活受体δ的激活会加速肠道腺瘤的生长。
Nat Med. 2004 Mar;10(3):245-7. doi: 10.1038/nm993. Epub 2004 Feb 1.
7
Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.在Apc(Min/+)小鼠的扁平发育异常的ACF和腺瘤中,PPARβ/δ和细胞周期蛋白D1水平升高。
Anticancer Res. 2005 Nov-Dec;25(6B):3781-9.
8
Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas.过氧化物酶体增殖物激活受体在正常人结肠上皮细胞和管状腺瘤中的表达与激活
Scand J Gastroenterol. 2005 Feb;40(2):198-205. doi: 10.1080/00365520410009573.
9
[Peroxisome proliferator-activated receptor (PPAR)].过氧化物酶体增殖物激活受体(PPAR)
Nihon Rinsho. 2001 Feb;59 Suppl 2:288-95.
10
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells.过氧化物酶体增殖物激活受体-β的敲低可诱导结肠癌细胞分化减少,并增强细胞与纤维连接蛋白的黏附。
Oncogene. 2010 Jan 28;29(4):516-26. doi: 10.1038/onc.2009.370. Epub 2009 Nov 23.

引用本文的文献

1
Identification of MMP14 and MKLN1 as colorectal cancer susceptibility genes and drug-repositioning candidates from a genome-wide association study.通过全基因组关联研究鉴定MMP14和MKLN1为结直肠癌易感基因及药物重新定位候选基因。
J Transl Med. 2025 May 14;23(1):543. doi: 10.1186/s12967-025-06491-6.
2
F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance.F-box蛋白22:一种与免疫浸润和化疗耐药相关的结肠癌预后生物标志物。
World J Gastrointest Oncol. 2025 Apr 15;17(4):102913. doi: 10.4251/wjgo.v17.i4.102913.
3
Regulatory role of PPAR in colorectal cancer.
过氧化物酶体增殖物激活受体(PPAR)在结直肠癌中的调节作用。
Cell Death Discov. 2025 Jan 28;11(1):28. doi: 10.1038/s41420-025-02313-2.
4
PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer.PPAR-δ作为一种预后生物标志物及其与乳腺癌免疫浸润的关联 PPAR-δ作为一种预后生物标志物及其与乳腺癌免疫浸润的关联。
J Cancer. 2023 Apr 17;14(6):1049-1061. doi: 10.7150/jca.81430. eCollection 2023.
5
Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes.基于结肠腺癌免疫相关基因的新型六基因预后签名。
BMC Bioinformatics. 2022 Oct 11;23(1):418. doi: 10.1186/s12859-022-04909-2.
6
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体与癌症的特征。
Cells. 2022 Aug 5;11(15):2432. doi: 10.3390/cells11152432.
7
(Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action.(芒果):一种用于乳腺癌治疗的有前景的药用植物及其潜在作用机制的研究
Breast Cancer (Dove Med Press). 2021 Sep 13;13:471-503. doi: 10.2147/BCTT.S316667. eCollection 2021.
8
PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis.过氧化物酶体增殖物激活受体与肿瘤微环境:代谢主调控因子在肿瘤基质-上皮细胞相互作用及致癌过程中的新作用
Cancers (Basel). 2021 Apr 29;13(9):2153. doi: 10.3390/cancers13092153.
9
Regulation of Intestinal Inflammation by Dietary Fats.膳食脂肪对肠道炎症的调节作用。
Front Immunol. 2021 Feb 2;11:604989. doi: 10.3389/fimmu.2020.604989. eCollection 2020.
10
PPAR Beta/Delta and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体-β/δ 与癌症的特征。
Cells. 2020 May 4;9(5):1133. doi: 10.3390/cells9051133.